Afinitor®, the Novartis trademark for the cancer fighter, everolimus, is used for the treatment of advanced renal cell carcinoma (RCC), inoperable cases of certain pancreatic cancers, and to aid successful acceptance of transplants. Now, the results of a Phase III study of Afinitor administered to women with advanced breast cancer have been announced, and the words used to describe the drug are "game changer."
Arthritis is a joint disease that results in a progressive loss of cartilage, just as osteoporosis results in progressive loss of bone. Though osteoporosis drugs are intended to regenerate bone growth, to date, arthritis drugs can only reduce inflammation and, thereby, reduce pain. But observation of patients taking a certain osteoporosis drug, by researchers at the University of Rochester Medical Center (URMC), led to the recent finding that this drug not only restored bone but cartilage as well.
Learning to walk again after breaking a leg or hip, having a stroke, prosthetic, or partial paralysis depends on a lot of persistence and an excellent rehabilitation program that can guide you through gait training. Movement scientist Dr. Melvyn Roerdink from The Netherlands has developed a super smart, oversized treadmill that helps rehab patients gain confidence in their new gaits, with bells, whistles, and even light shows.
The U.S. Department of Agriculture (USDA) revamped its healthy eating recommendations a few months ago with a new visual - an icon called 'MyPlate,' replacing the former healthy foods pyramid icon. The Nutrition Source at the Harvard School of Public Health thinks the government's plate lacks a good bit of guidance as to which specific foods should be eaten - after all MyPlate offers no guidance.
For many of the 13 million Americans currently at risk for non-melanoma skin cancers, the VivoSight® Optical Coherence Tomography (OCT) scanner will be a blessing in their dermatologists' tool closet. The device, just approved for clinical use by the FDA, offers real-time laser imaging of a patient's skin, enabling better, and sometimes immediate, treatment of basal or squamous cell cancers.
Scientists at the University of Southern California (USC) and the Mayo Clinic College of Medicine just achieved a scientific breakthrough that has the potential to revolutionize the design of neurological drugs: they captured the first high resolution images of the acetylcholine receptor (AChR), the α7 molecule responsible for transmitting signals between neurons, particularly those associated with learning and memory.
It's so great to find innovations for disabled people on design websites, rather than buried in disability association files. "Design" says the world is paying attention to disability needs, and it cares that the latest technologies are employed in the tools and that they look pretty cool too. The Finger Reader is at least the second design for blind and visually impaired persons by Hansub Lee and it's a great accessibility creation for finding exactly what you want while shopping.
Historically, surgical removal or oral and throat cancers have not allowed patients to go back to living their normal daily lives. Oral cancer removals caused severe pain, particularly ugly scarring, and an inability to eat, speak, or swallow normally. Even breathing problems might result. But now along comes TORS, the robot with the right stuff.
Canadian researchers have made cancer treatment history with the success of an intravenous infusion of a virus, JX-594. The virus was injected into 23 patients with advanced and metastasized cancers who had not responded to traditional therapies. Not only was this the first test of viral therapy on human cancer patients, but the first trial to introduce a targeted virus intravenously.